OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!

Dr. Dino Prato - Envita Medical Centers
  • 5.0 (3)
  • ALTERNATIVE HEALTH

OutSmart Cancer is the podcast for people who refuse to settle for one-size-fits-all cancer care. Hosted by Dr. Dino Prato, founder of Envita Medical Centers, this show offers expert insight into the world of precision oncology, integrative treatments, and the hidden factors that make cancer so hard to treat — and what to do about them. For the last 25 years, Dr. Prato and his team have helped thousands of patients that have failed the largest hospitals utilizing the techniques and technology discussed in this series. Whether you’ve been newly diagnosed, are navigating treatment resistance, or want a second opinion grounded in science and compassion, you’ll hear empowering discussions on: DNA, RNA, and immune-based targeting, the truth behind standard protocols, what most doctors miss in treatment planning, stories of hope from patients who’ve been told “there’s nothing more we can do” We believe in personalized, data-driven medicine — not protocol-based guessing.You don’t have to fight cancer blindly. You can OutSmart it. Disclaimer:  This podcast is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before making medical decisions. Results vary and no specific outcomes are guaranteed. Some treatments may not be FDA-approved or available in all locations. Testimonials reflect individual experiences and may not represent typical outcomes. Certain therapies may be offered only at Envita’s international clinic in Hermosillo, Mexico. 

  1. 6H AGO

    40% of Cancers Are Preventable — Here’s What That Means | Dr. Dino Prato

    Six hundred thousand Americans will die from cancer this year, but many of these deaths are preventable. Dr. Prato highlights that early detection and new approaches to cancer prevention could drastically improve outcomes and reduce mortality. We explore the importance of holistic health and effective treatment strategies in oncology to ensure fewer lives are lost to this disease. 🎯 What You’ll Learn in This Episode • What the “40% of cancers are preventable” statistic means • Key lifestyle and environmental risk factors • The role of infections in cancer risk • Why early detection improves outcomes • What multi-cancer early detection (MCED) tests are • How metabolic and immune health influence cancer risk • The difference between prevention and treatment strategies • Why individualized approaches are becoming more important 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “Prevention and early detection may change the trajectory of cancer care.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493

    11 min

  2. 1D AGO

    This New Cancer Device Just Got FDA Approval

    A new device has received food and drug administration approval for pancreatic cancer, offering a new tool in cancer treatment.  This wearable technology works by disrupting cancer cells, potentially slowing growth. While not a cure, this development in medical research provides a valuable addition to oncology strategies, buying time for patients. 🎯 What You’ll Learn in This Episode • What Tumor Treating Fields actually are • How the Optune device works • Why pancreatic cancer is difficult to treat • Why slowing tumor division may buy valuable treatment time • The limitations of IV chemotherapy delivery to pancreatic tumors • Why immune activation is critical for long-term response • How multi-omics testing identifies personalized targets • Why new technologies should be combined with precision strategies 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “New technology can slow cancer — but long-term control often depends on activating the immune system.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493

    8 min

  3. 2D AGO

    Why Viral Cancer Cure Claims Spread So Fast (And Why You Should Be Skeptical)

    In early 2026, social media buzzed with claims of a 100% success rate for free cancer vaccines, raising hopes for patients eager for a medical breakthrough. This news highlights how cancer treatment can become a tool in geopolitics and global politics, as nations vie for influence. It's crucial to understand these social media trends and approach such information with critical thinking. 🎯 What You’ll Learn in This Episode • Why viral “100% cure” headlines spread so quickly online • The difference between early research and clinical treatment • How cancer vaccines and mRNA therapies are being studied • Why cancer remains biologically complex and individualized • What multi-omics testing means in oncology • Why tumor genetics and immune markers matter • How precision oncology evaluates treatment options • Why patients should evaluate headlines carefully before making treatment decisions 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “Cancer headlines move fast — but treatment decisions should always be guided by data.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493

    14 min

  4. 3D AGO

    Peptides & Cancer — The Dangerous Ones You Must Avoid | Dr. Dino Prato

    Dr. Prato explores the promising field of peptide therapy, highlighting how these powerful compounds can contribute to healthy aging and overall wellness. We discuss the potential for peptides to support joint health and bone health, offering a new perspective on maintaining physical vitality. The research also suggests benefits for brain health, making peptides a fascinating area of study for those interested in anti-aging strategies. 🎯 What You’ll Learn in This Episode: - What peptides actually are - Why timing matters during chemotherapy - Which peptides may stimulate growth pathways - Which peptides may support immune signaling - The risks of black-market peptide sourcing - Why diet, sleep, and gut health come first - How precision oncology integrates immune support safely - The importance of physician supervision 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “Peptides don’t heal chaos — they amplify signals. Make sure the signal is the right one.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493

    16 min

  5. 4D AGO

    Bioidentical Hormones, Circulation, and Rebuilding Intimacy Post-Cancer

    Cancer treatment can profoundly affect intimacy and marital connection, often leading to challenges in sexual health and relationships. Many couples face issues like decreased sexual function and confidence after chemotherapy, yet these challenges are not insurmountable. Dr. Prato provides practical marriage advice and integrative tools to help navigate these impacts, offering hope and solutions for a fulfilling connection post-treatment. 🎯 What You’ll Learn in This Episode: - Why cancer treatment affects libido and performance - The role of sleep and cortisol in sexual health - When bioidentical hormones may be appropriate - Safe considerations for testosterone microdosing - When localized estriol therapy may be considered - The role of circulation in erectile function - Natural nitric oxide support strategies - Why emotional connection matters just as much as biology 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “Intimacy is not lost after cancer — it must be rebuilt with wisdom, patience, and the right support.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493

    17 min

  6. APR 3

    Cancer Survival Rates Exposed: What American Cancer Society Isn’t Telling You

    When a loved one faces metastatic cancer, the outlook can be challenging, with significantly low survival rates for conditions like lung cancer and breast cancer.  Dr. Prato highlights the stark reality of cancer cells spreading, contrasting the American Cancer Society's optimistic 70% overall survival rate with the grim statistics for a cancer patient with advanced disease. Understanding the nuances of cancer treatment and its efficacy against metastasis is crucial. 🎯 What You’ll Learn in This Episode • What the “70% cancer survival” statistic actually represents • Why early-stage and metastatic cancers have very different outcomes • Why stage-specific survival data matters for patients • How early detection dramatically improves outcomes • What multi-cancer early detection testing is • How multi-omics testing helps guide treatment decisions • The role of immune profiling in cancer treatment strategies • Why personalized oncology approaches are growing in importance 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “Cancer statistics describe populations — but treatment decisions must focus on the individual.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493

    14 min

  7. APR 2

    Mold Toxins: Why Most Cancer Treatments Fail Without Addressing This

    Many cancer patients face a dual challenge: battling the tumor and an invisible enemy—infections from mold and mycotoxins.  Dr. Prato explores how water-damaged buildings can harbor toxic mold, often overlooked by standard oncology practices. We highlight the critical need to address environmental health factors like mold exposure as potential root causes, ensuring comprehensive patient care alongside traditional cancer treatment. 🎯 What You’ll Learn in This Episode: - The difference between mold spores and mycotoxins - How mold exposure can stress the immune system - What CIRS (chronic inflammatory response syndrome) means - Why inflammation complicates cancer recovery - The role of binders and detox support (under medical care) - What MARCoNS biofilm infections are - Why immune balance (TH1/TH2) matters - The right questions to ask about mold testing 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “You can’t rebuild immunity while something is quietly breaking it.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493

    11 min

  8. APR 1

    Pancreatic Cancer Breakthrough | How Multi-Target Strategy Stops Tumors Dead

    A Spanish research team achieved remarkable results, making pancreatic cancer tumors disappear in mice by targeting multiple escape routes simultaneously. This approach prevented tumor recurrence and resistance, highlighting a design strategy central to precision cancer medicine. Dr. Dino Prato discusses how this mirrors the principles of targeted cancer therapy, emphasizing the importance of understanding the tumor microenvironment for effective cancer care. 🎯 What You’ll Learn in This Episode: - Why pancreatic cancer is so difficult to treat - What KRAS, EGFR, and STAT3 do - How tumors develop resistance - What the triple-lock strategy means - Why mouse data doesn’t always translate to humans - The difference between one-size-fits-all and precision oncology - Why immune activation matters for long-term control - Questions to ask your doctor about pathway targeting 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “Cancer adapts — so treatment must adapt faster.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at:  https://www.scirp.org/journal/paperinformation?paperid=132493

    10 min
See All (97)

Ratings & Reviews

5
out of 5
3 Ratings

About

OutSmart Cancer is the podcast for people who refuse to settle for one-size-fits-all cancer care. Hosted by Dr. Dino Prato, founder of Envita Medical Centers, this show offers expert insight into the world of precision oncology, integrative treatments, and the hidden factors that make cancer so hard to treat — and what to do about them. For the last 25 years, Dr. Prato and his team have helped thousands of patients that have failed the largest hospitals utilizing the techniques and technology discussed in this series. Whether you’ve been newly diagnosed, are navigating treatment resistance, or want a second opinion grounded in science and compassion, you’ll hear empowering discussions on: DNA, RNA, and immune-based targeting, the truth behind standard protocols, what most doctors miss in treatment planning, stories of hope from patients who’ve been told “there’s nothing more we can do” We believe in personalized, data-driven medicine — not protocol-based guessing.You don’t have to fight cancer blindly. You can OutSmart it. Disclaimer:  This podcast is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before making medical decisions. Results vary and no specific outcomes are guaranteed. Some treatments may not be FDA-approved or available in all locations. Testimonials reflect individual experiences and may not represent typical outcomes. Certain therapies may be offered only at Envita’s international clinic in Hermosillo, Mexico. 

Information

You Might Also Like